Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.96M Buy
61,682
+28,730
+87% +$3.97M 0.34% 58
2026
Q2
$4.23M Sell
32,952
-3,981
-11% -$466K 0.16% 143
2026
Q1
$4.44M Sell
36,933
-15,868
-30% -$1.83M 0.21% 107
2025
Q4
$5.56M Buy
52,801
+21,073
+66% +$1.98M 0.26% 81
2025
Q3
$2.66M Sell
31,728
-2,687
-8% -$221K 0.13% 197
2025
Q2
$2.72M Sell
34,415
-3,640
-10% -$289K 0.14% 174
2025
Q1
$3.42M Buy
+38,055
New +$3.55M 0.2% 132

Other funds holding MRK

Bolton Securities's MRK Position: Q3 2026 in Review

Bolton Securities increased its Merck (MRK) stake by 87% in Q3 2026, buying an estimated $3.97M and bringing the position to 61,682 shares worth $8.96M. The position accounts for 0.34% of the portfolio, ranked #58.

Bolton Securities first reported a position in MRK in Q1 2025 and has held it in 7 quarters since. 3,978 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Bolton Securities held 61,682 shares of Merck worth $8.96M as of Q3 2026.
  • Bolton Securities bought 28,730 Merck shares in Q3 2026, an estimated $3.97M.
  • Merck made up 0.34% of Bolton Securities's portfolio in Q3 2026, its #58 holding.
  • Bolton Securities first reported a position in Merck in Q1 2025 and has held it in 7 quarters since.
  • 3,978 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.